Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 09:34 am Purchase | 2024-09-30 | 13G | Nkarta, Inc. NKTX | Adage Capital Management, L.P. | 3,600,000 5.100% | 3,600,000 (New Position) | Filing History |
| 2024-11-12 09:34 am Purchase | 2024-09-30 | 13G | Sutro Biopharma, Inc. STRO | Adage Capital Management, L.P. | 2,250,132 2.750% | 2,250,132 (New Position) | Filing History |
| 2024-11-12 09:34 am Purchase | 2024-09-30 | 13G | Veru Inc. VERU | Adage Capital Management, L.P. | 786,111 5.370% | 786,111 (New Position) | Filing History |
| 2024-11-12 09:34 am Purchase | 2024-09-30 | 13G | Cabaletta Bio, Inc. CABA | Adage Capital Management, L.P. | 3,634,475 7.430% | 3,634,475 (New Position) | Filing History |
| 2024-11-12 09:34 am Purchase | 2024-09-30 | 13G | Wave Life Sciences Ltd. WVE | Adage Capital Management, L.P. | 9,703,351 6.660% | 9,703,351 (New Position) | Filing History |
| 2024-11-12 09:34 am Unchanged | 2024-09-30 | 13G | Vinci Compass Investments Ltd. VINP | Adage Capital Management, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-11-12 09:33 am Sale | 2024-09-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | Adage Capital Management, L.P. | 3,791,420 7.080% | -1,364,879 (-26.47%) | Filing History |
| 2024-11-12 09:33 am Purchase | 2024-09-30 | 13G | Soleno Therapeutics, Inc. SLNO | Adage Capital Management, L.P. | 3,322,146 8.550% | 3,322,146 (New Position) | Filing History |
| 2024-11-12 09:32 am Purchase | 2024-09-30 | 13G | Aura Biosciences, Inc. AURA | Adage Capital Management, L.P. | 4,881,125 9.840% | 4,881,125 (New Position) | Filing History |
| 2024-11-12 09:32 am Purchase | 2024-09-30 | 13G | Tenax Therapeutics, Inc. TENX | Adage Capital Management, L.P. | 369,097 9.990% | 369,097 (New Position) | Filing History |
| 2024-11-12 09:32 am Purchase | 2024-09-30 | 13G | Heron Therapeutics, Inc. HRTX | Adage Capital Management, L.P. | 8,850,000 5.840% | 8,850,000 (New Position) | Filing History |
| 2024-11-12 09:31 am Purchase | 2024-09-30 | 13G | Immunic, Inc. IMUX | Adage Capital Management, L.P. | 5,594,406 6.210% | 5,594,406 (New Position) | Filing History |
| 2024-11-12 09:31 am Unchanged | 2024-09-30 | 13G | Molecular Templates, Inc. MTEM | Adage Capital Management, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-11-12 09:31 am Purchase | 2024-09-30 | 13G | Aligos Therapeutics, Inc. ALGS | Adage Capital Management, L.P. | 218,813 7.120% | 218,813 (New Position) | Filing History |
| 2024-11-12 09:31 am Purchase | 2024-09-30 | 13G | KalVista Pharmaceuticals, Inc. KALV | Adage Capital Management, L.P. | 1,419,792 3.290% | 1,419,792 (New Position) | Filing History |
| 2024-11-12 09:31 am Purchase | 2024-09-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Adage Capital Management, L.P. | 2,597,736 7.860% | 2,597,736 (New Position) | Filing History |
| 2024-11-12 09:30 am Purchase | 2024-09-30 | 13G | UroGen Pharma Ltd. URGN | Adage Capital Management, L.P. | 3,735,741 8.870% | 3,735,741 (New Position) | Filing History |
| 2024-11-12 09:30 am Purchase | 2024-09-30 | 13G | Solid Biosciences Inc. SLDB | Adage Capital Management, L.P. | 1,754,159 4.550% | 1,754,159 (New Position) | Filing History |
| 2024-11-12 09:30 am Purchase | 2024-09-30 | 13G | enGene Holdings Inc. ENGN | Adage Capital Management, L.P. | 2,329,768 5.270% | 2,329,768 (New Position) | Filing History |
| 2024-11-04 4:26 pm Purchase | 2024-10-29 | 13D | GlycoMimetics, Inc. GLYC | Adage Capital Management, L.P. | 50,912 7.900% | 50,912 (New Position) | Filing History |